0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Clinical Molecular Imaging System Market Research Report 2026
Published Date: 2026-02-03
|
Report Code: QYRE-Auto-23T18150
Home | Market Reports | Health| Nursing
Global Clinical Molecular Imaging System Market Research Report 2024
BUY CHAPTERS

Global Clinical Molecular Imaging System Market Research Report 2026

Code: QYRE-Auto-23T18150
Report
2026-02-03
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Clinical Molecular Imaging System Market Size

The global Clinical Molecular Imaging System market was valued at US$ 602 million in 2025 and is anticipated to reach US$ 954 million by 2032, at a CAGR of 6.9% from 2026 to 2032.

Clinical Molecular Imaging System Market

Clinical Molecular Imaging System Market

Molecular imaging (MI) is a medical imaging technology that combines multiple disciplines, such as medical imaging technology, molecular biology, radiology, computer science, etc., and performs imaging by detecting radioactive markers or other imaging probes in the human body. Molecular imaging systems are high-end products in the field of medical imaging, and the main market participants are internationally renowned medical equipment manufacturers. With the continuous advancement of technology and the increase in clinical needs, the market prospects for molecular imaging systems are broad. In the future, digital technology, artificial intelligence algorithms, etc. will further enhance the performance and clinical application value of molecular imaging systems.In terms of the industry chain, the upstream involves the research and development of probes and tracers, the supply of radioisotopes/labels, and the manufacturing of detectors and core imaging devices; the midstream involves the supply of complete imaging systems (including hardware and software); and the downstream provides services and applications for hospitals, imaging diagnostic centers, and pharmaceutical/research institutions.The industry's gross profit margin is approximately 40-60%.
The main market drivers for clinical molecular imaging systems include:
Rising Disease Burden and Demand for Personalized Medicine
With the increasing aging of the global population, changing lifestyles, and environmental factors, the incidence of chronic and major diseases such as cancer, cardiovascular disease, neurological disorders, and metabolic syndrome continues to rise. This has led to a growing demand in healthcare systems for early detection, precise diagnosis, and monitoring of treatment response. Traditional imaging (such as CT and MRI) focuses primarily on structural changes, often revealing symptoms only after disease progression. Molecular imaging systems, however, can capture disease processes at the molecular or cellular level, enabling early diagnosis. Therefore, clinical institutions, imaging centers, and pharmaceutical R&D are increasingly willing to deploy molecular imaging systems that support pre-treatment, during-treatment, and post-treatment monitoring. Furthermore, with the rise of precision medicine, targeted therapy, and immunotherapy, imaging systems must possess higher sensitivity and earlier sign-capturing capabilities in scenarios such as patient segmentation, efficacy evaluation, and recurrence monitoring. As a result, the "molecular probe + imaging system + analysis service" combination offered by system manufacturers has ushered in a market expansion opportunity.
Technological innovation and improved imaging performance promote adoption. From a technical perspective, molecular imaging systems have experienced rapid development in recent years. Typical examples include the increasingly mature hybrid modalities of PET/SPECT and CT/MRI (e.g., PET-CT, PET-MR), which improve localization accuracy and diagnostic value by fusing functional images with anatomical structural images. ([Grand Vision Research][1]) Upgrades in detector materials, improvements in image reconstruction algorithms, artificial intelligence (AI)-assisted analysis, increased data processing speed, shorter scan times, and improved comfort are all enhancing user experience and clinical usability. ([Research and Markets][2]) Furthermore, the research and development of molecular imaging tracers and probes is constantly deepening, making imaging with more targets, higher sensitivity, and lower doses possible. While the technical threshold and equipment complexity are high, this very high level of complexity also constitutes a barrier to market entry, giving manufacturers with existing technological, channel, and service capabilities an advantage. Furthermore, emerging technologies such as long-axis field-of-view (LAFOV) PET/CT are expanding imaging capabilities, leading to a continuous broadening of clinical applications. ([arXiv][3]) Therefore, technological innovation provides a powerful driving force for system upgrades.
Expansion of Medical Infrastructure, Innovation in Service Models, and the Rise of Emerging Markets
From a macro perspective, multiple factors have converged to drive the market penetration of molecular imaging systems. First, many countries worldwide have increased healthcare spending, promoted the construction of medical infrastructure, and improved the configuration of imaging diagnostic centers, leading to increased demand for advanced imaging equipment in hospitals and diagnostic centers. Second, outside of hospitals, diagnostic service outsourcing, imaging centers, and clinical trial service companies are also increasingly emphasizing the capabilities of imaging systems, especially in new drug development and efficacy monitoring, where imaging has become a key link. ([Towards Healthcare][4]) Furthermore, emerging market countries (such as Asia, Latin America, and parts of the Middle East and Africa) have growth potential in terms of upgrading medical equipment and improving diagnostic capabilities. With their large populations, heavy disease burdens, and increased awareness of advanced imaging equipment, the market opportunities for molecular imaging systems are also growing. Finally, from a business model perspective, equipment manufacturers and service providers are shifting towards a "system + software + service" model. Image analysis platforms, quantitative tools, AI-assisted diagnosis, imaging service contracts, and remote support are becoming new value-added points, thereby increasing overall profitability and strengthening market appeal. In summary, the expansion of medical infrastructure, service model innovation, and the rise of emerging markets have collectively strengthened the market driving force of this system.
This report delivers a comprehensive overview of the global Clinical Molecular Imaging System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Clinical Molecular Imaging System. The Clinical Molecular Imaging System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Clinical Molecular Imaging System market comprehensively. Regional market sizes by Type, by Application, by Technology, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Clinical Molecular Imaging System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Clinical Molecular Imaging System Market Report

Report Metric Details
Report Name Clinical Molecular Imaging System Market
Accounted market size in 2025 US$ 602 million
Forecasted market size in 2032 US$ 954 million
CAGR 6.9%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Fixed
  • Mobile
Segment by Technology
  • Radiological Nuclear Medicine Imaging
  • Magnetic Resonance Molecular Imaging
  • Optical Molecular Imaging
  • Other
Segment by Product Forms
  • PET Scanning Systems
  • Gamma Camera Systems
  • Hybrid Systems
  • Other
Segment by Application
  • Hospital
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Philips, GE Healthcare, Siemens, GMM, Hitachi, United-imaging, Shinva Medical, Kangda Medical, Wandong Medical, Canon Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technology, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for Clinical Molecular Imaging System companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Clinical Molecular Imaging System Market growing?

Ans: The Clinical Molecular Imaging System Market witnessing a CAGR of 6.9% during the forecast period 2026-2032.

What is the Clinical Molecular Imaging System Market size in 2032?

Ans: The Clinical Molecular Imaging System Market size in 2032 will be US$ 954 million.

Who are the main players in the Clinical Molecular Imaging System Market report?

Ans: The main players in the Clinical Molecular Imaging System Market are Philips, GE Healthcare, Siemens, GMM, Hitachi, United-imaging, Shinva Medical, Kangda Medical, Wandong Medical, Canon Medical

What are the Application segmentation covered in the Clinical Molecular Imaging System Market report?

Ans: The Applications covered in the Clinical Molecular Imaging System Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Clinical Molecular Imaging System Market report?

Ans: The Types covered in the Clinical Molecular Imaging System Market report are Fixed, Mobile

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Clinical Molecular Imaging System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Fixed
1.2.3 Mobile
1.3 Market by Technology
1.3.1 Global Clinical Molecular Imaging System Market Size Growth Rate by Technology: 2021 vs 2025 vs 2032
1.3.2 Radiological Nuclear Medicine Imaging
1.3.3 Magnetic Resonance Molecular Imaging
1.3.4 Optical Molecular Imaging
1.3.5 Other
1.4 Market by Product Forms
1.4.1 Global Clinical Molecular Imaging System Market Size Growth Rate by Product Forms: 2021 vs 2025 vs 2032
1.4.2 PET Scanning Systems
1.4.3 Gamma Camera Systems
1.4.4 Hybrid Systems
1.4.5 Other
1.5 Market by Application
1.5.1 Global Clinical Molecular Imaging System Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Clinical Molecular Imaging System Market Perspective (2021–2032)
2.2 Global Clinical Molecular Imaging System Growth Trends by Region
2.2.1 Global Clinical Molecular Imaging System Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Clinical Molecular Imaging System Historic Market Size by Region (2021–2026)
2.2.3 Clinical Molecular Imaging System Forecasted Market Size by Region (2027–2032)
2.3 Clinical Molecular Imaging System Market Dynamics
2.3.1 Clinical Molecular Imaging System Industry Trends
2.3.2 Clinical Molecular Imaging System Market Drivers
2.3.3 Clinical Molecular Imaging System Market Challenges
2.3.4 Clinical Molecular Imaging System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Clinical Molecular Imaging System Players by Revenue
3.1.1 Global Top Clinical Molecular Imaging System Players by Revenue (2021–2026)
3.1.2 Global Clinical Molecular Imaging System Revenue Market Share by Players (2021–2026)
3.2 Global Top Clinical Molecular Imaging System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Clinical Molecular Imaging System Revenue
3.4 Global Clinical Molecular Imaging System Market Concentration Ratio
3.4.1 Global Clinical Molecular Imaging System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Clinical Molecular Imaging System Revenue in 2025
3.5 Global Key Players of Clinical Molecular Imaging System Head Offices and Areas Served
3.6 Global Key Players of Clinical Molecular Imaging System, Products and Applications
3.7 Global Key Players of Clinical Molecular Imaging System, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Clinical Molecular Imaging System Breakdown Data by Type
4.1 Global Clinical Molecular Imaging System Historic Market Size by Type (2021–2026)
4.2 Global Clinical Molecular Imaging System Forecasted Market Size by Type (2027–2032)
5 Clinical Molecular Imaging System Breakdown Data by Application
5.1 Global Clinical Molecular Imaging System Historic Market Size by Application (2021–2026)
5.2 Global Clinical Molecular Imaging System Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Clinical Molecular Imaging System Market Size (2021–2032)
6.2 North America Clinical Molecular Imaging System Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Clinical Molecular Imaging System Market Size by Country (2021–2026)
6.4 North America Clinical Molecular Imaging System Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Clinical Molecular Imaging System Market Size (2021–2032)
7.2 Europe Clinical Molecular Imaging System Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Clinical Molecular Imaging System Market Size by Country (2021–2026)
7.4 Europe Clinical Molecular Imaging System Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Clinical Molecular Imaging System Market Size (2021–2032)
8.2 Asia-Pacific Clinical Molecular Imaging System Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Clinical Molecular Imaging System Market Size by Region (2021–2026)
8.4 Asia-Pacific Clinical Molecular Imaging System Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Clinical Molecular Imaging System Market Size (2021–2032)
9.2 Latin America Clinical Molecular Imaging System Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Clinical Molecular Imaging System Market Size by Country (2021–2026)
9.4 Latin America Clinical Molecular Imaging System Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Clinical Molecular Imaging System Market Size (2021–2032)
10.2 Middle East & Africa Clinical Molecular Imaging System Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Clinical Molecular Imaging System Market Size by Country (2021–2026)
10.4 Middle East & Africa Clinical Molecular Imaging System Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Philips
11.1.1 Philips Company Details
11.1.2 Philips Business Overview
11.1.3 Philips Clinical Molecular Imaging System Introduction
11.1.4 Philips Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.1.5 Philips Recent Development
11.2 GE Healthcare
11.2.1 GE Healthcare Company Details
11.2.2 GE Healthcare Business Overview
11.2.3 GE Healthcare Clinical Molecular Imaging System Introduction
11.2.4 GE Healthcare Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.2.5 GE Healthcare Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Clinical Molecular Imaging System Introduction
11.3.4 Siemens Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.3.5 Siemens Recent Development
11.4 GMM
11.4.1 GMM Company Details
11.4.2 GMM Business Overview
11.4.3 GMM Clinical Molecular Imaging System Introduction
11.4.4 GMM Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.4.5 GMM Recent Development
11.5 Hitachi
11.5.1 Hitachi Company Details
11.5.2 Hitachi Business Overview
11.5.3 Hitachi Clinical Molecular Imaging System Introduction
11.5.4 Hitachi Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.5.5 Hitachi Recent Development
11.6 United-imaging
11.6.1 United-imaging Company Details
11.6.2 United-imaging Business Overview
11.6.3 United-imaging Clinical Molecular Imaging System Introduction
11.6.4 United-imaging Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.6.5 United-imaging Recent Development
11.7 Shinva Medical
11.7.1 Shinva Medical Company Details
11.7.2 Shinva Medical Business Overview
11.7.3 Shinva Medical Clinical Molecular Imaging System Introduction
11.7.4 Shinva Medical Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.7.5 Shinva Medical Recent Development
11.8 Kangda Medical
11.8.1 Kangda Medical Company Details
11.8.2 Kangda Medical Business Overview
11.8.3 Kangda Medical Clinical Molecular Imaging System Introduction
11.8.4 Kangda Medical Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.8.5 Kangda Medical Recent Development
11.9 Wandong Medical
11.9.1 Wandong Medical Company Details
11.9.2 Wandong Medical Business Overview
11.9.3 Wandong Medical Clinical Molecular Imaging System Introduction
11.9.4 Wandong Medical Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.9.5 Wandong Medical Recent Development
11.10 Canon Medical
11.10.1 Canon Medical Company Details
11.10.2 Canon Medical Business Overview
11.10.3 Canon Medical Clinical Molecular Imaging System Introduction
11.10.4 Canon Medical Revenue in Clinical Molecular Imaging System Business (2021–2026)
11.10.5 Canon Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Clinical Molecular Imaging System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Fixed
 Table 3. Key Players of Mobile
 Table 4. Global Clinical Molecular Imaging System Market Size Growth Rate by Technology (US$ Million): 2021 vs 2025 vs 2032
 Table 5. Key Players of Radiological Nuclear Medicine Imaging
 Table 6. Key Players of Magnetic Resonance Molecular Imaging
 Table 7. Key Players of Optical Molecular Imaging
 Table 8. Key Players of Other
 Table 9. Global Clinical Molecular Imaging System Market Size Growth Rate by Product Forms (US$ Million): 2021 vs 2025 vs 2032
 Table 10. Key Players of PET Scanning Systems
 Table 11. Key Players of Gamma Camera Systems
 Table 12. Key Players of Hybrid Systems
 Table 13. Key Players of Other
 Table 14. Global Clinical Molecular Imaging System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 15. Global Clinical Molecular Imaging System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 16. Global Clinical Molecular Imaging System Market Size by Region (US$ Million), 2021–2026
 Table 17. Global Clinical Molecular Imaging System Market Share by Region (2021–2026)
 Table 18. Global Clinical Molecular Imaging System Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 19. Global Clinical Molecular Imaging System Market Share by Region (2027–2032)
 Table 20. Clinical Molecular Imaging System Market Trends
 Table 21. Clinical Molecular Imaging System Market Drivers
 Table 22. Clinical Molecular Imaging System Market Challenges
 Table 23. Clinical Molecular Imaging System Market Restraints
 Table 24. Global Clinical Molecular Imaging System Revenue by Players (US$ Million), 2021–2026
 Table 25. Global Clinical Molecular Imaging System Market Share by Players (2021–2026)
 Table 26. Global Top Clinical Molecular Imaging System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Clinical Molecular Imaging System Revenue, 2025
 Table 27. Ranking of Global Top Clinical Molecular Imaging System Companies by Revenue (US$ Million) in 2025
 Table 28. Global 5 Largest Players Market Share by Clinical Molecular Imaging System Revenue (CR5 and HHI), 2021–2026
 Table 29. Global Key Players of Clinical Molecular Imaging System, Headquarters and Area Served
 Table 30. Global Key Players of Clinical Molecular Imaging System, Products and Applications
 Table 31. Global Key Players of Clinical Molecular Imaging System, Date of General Availability (GA)
 Table 32. Mergers and Acquisitions, Expansion Plans
 Table 33. Global Clinical Molecular Imaging System Market Size by Type (US$ Million), 2021–2026
 Table 34. Global Clinical Molecular Imaging System Revenue Market Share by Type (2021–2026)
 Table 35. Global Clinical Molecular Imaging System Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 36. Global Clinical Molecular Imaging System Revenue Market Share by Type (2027–2032)
 Table 37. Global Clinical Molecular Imaging System Market Size by Application (US$ Million), 2021–2026
 Table 38. Global Clinical Molecular Imaging System Revenue Market Share by Application (2021–2026)
 Table 39. Global Clinical Molecular Imaging System Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 40. Global Clinical Molecular Imaging System Revenue Market Share by Application (2027–2032)
 Table 41. North America Clinical Molecular Imaging System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 42. North America Clinical Molecular Imaging System Market Size by Country (US$ Million), 2021–2026
 Table 43. North America Clinical Molecular Imaging System Market Size by Country (US$ Million), 2027–2032
 Table 44. Europe Clinical Molecular Imaging System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 45. Europe Clinical Molecular Imaging System Market Size by Country (US$ Million), 2021–2026
 Table 46. Europe Clinical Molecular Imaging System Market Size by Country (US$ Million), 2027–2032
 Table 47. Asia-Pacific Clinical Molecular Imaging System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 48. Asia-Pacific Clinical Molecular Imaging System Market Size by Region (US$ Million), 2021–2026
 Table 49. Asia-Pacific Clinical Molecular Imaging System Market Size by Region (US$ Million), 2027–2032
 Table 50. Latin America Clinical Molecular Imaging System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 51. Latin America Clinical Molecular Imaging System Market Size by Country (US$ Million), 2021–2026
 Table 52. Latin America Clinical Molecular Imaging System Market Size by Country (US$ Million), 2027–2032
 Table 53. Middle East & Africa Clinical Molecular Imaging System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 54. Middle East & Africa Clinical Molecular Imaging System Market Size by Country (US$ Million), 2021–2026
 Table 55. Middle East & Africa Clinical Molecular Imaging System Market Size by Country (US$ Million), 2027–2032
 Table 56. Philips Company Details
 Table 57. Philips Business Overview
 Table 58. Philips Clinical Molecular Imaging System Product
 Table 59. Philips Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 60. Philips Recent Development
 Table 61. GE Healthcare Company Details
 Table 62. GE Healthcare Business Overview
 Table 63. GE Healthcare Clinical Molecular Imaging System Product
 Table 64. GE Healthcare Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 65. GE Healthcare Recent Development
 Table 66. Siemens Company Details
 Table 67. Siemens Business Overview
 Table 68. Siemens Clinical Molecular Imaging System Product
 Table 69. Siemens Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 70. Siemens Recent Development
 Table 71. GMM Company Details
 Table 72. GMM Business Overview
 Table 73. GMM Clinical Molecular Imaging System Product
 Table 74. GMM Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 75. GMM Recent Development
 Table 76. Hitachi Company Details
 Table 77. Hitachi Business Overview
 Table 78. Hitachi Clinical Molecular Imaging System Product
 Table 79. Hitachi Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 80. Hitachi Recent Development
 Table 81. United-imaging Company Details
 Table 82. United-imaging Business Overview
 Table 83. United-imaging Clinical Molecular Imaging System Product
 Table 84. United-imaging Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 85. United-imaging Recent Development
 Table 86. Shinva Medical Company Details
 Table 87. Shinva Medical Business Overview
 Table 88. Shinva Medical Clinical Molecular Imaging System Product
 Table 89. Shinva Medical Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 90. Shinva Medical Recent Development
 Table 91. Kangda Medical Company Details
 Table 92. Kangda Medical Business Overview
 Table 93. Kangda Medical Clinical Molecular Imaging System Product
 Table 94. Kangda Medical Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 95. Kangda Medical Recent Development
 Table 96. Wandong Medical Company Details
 Table 97. Wandong Medical Business Overview
 Table 98. Wandong Medical Clinical Molecular Imaging System Product
 Table 99. Wandong Medical Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 100. Wandong Medical Recent Development
 Table 101. Canon Medical Company Details
 Table 102. Canon Medical Business Overview
 Table 103. Canon Medical Clinical Molecular Imaging System Product
 Table 104. Canon Medical Revenue in Clinical Molecular Imaging System Business (US$ Million), 2021–2026
 Table 105. Canon Medical Recent Development
 Table 106. Research Programs/Design for This Report
 Table 107. Key Data Information from Secondary Sources
 Table 108. Key Data Information from Primary Sources
 Table 109. Authors List of This Report


List of Figures
 Figure 1. Clinical Molecular Imaging System Picture
 Figure 2. Global Clinical Molecular Imaging System Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global Clinical Molecular Imaging System Market Share by Type: 2025 vs 2032
 Figure 4. Fixed Features
 Figure 5. Mobile Features
 Figure 6. Global Clinical Molecular Imaging System Market Size Comparison by Technology (US$ Million), 2021–2032
 Figure 7. Radiological Nuclear Medicine Imaging Features
 Figure 8. Magnetic Resonance Molecular Imaging Features
 Figure 9. Optical Molecular Imaging Features
 Figure 10. Other Features
 Figure 11. Global Clinical Molecular Imaging System Market Size Comparison by Product Forms (US$ Million), 2021–2032
 Figure 12. PET Scanning Systems Features
 Figure 13. Gamma Camera Systems Features
 Figure 14. Hybrid Systems Features
 Figure 15. Other Features
 Figure 16. Global Clinical Molecular Imaging System Market Size by Application (US$ Million), 2021–2032
 Figure 17. Global Clinical Molecular Imaging System Market Share by Application: 2025 vs 2032
 Figure 18. Hospital Case Studies
 Figure 19. Clinic Case Studies
 Figure 20. Other Case Studies
 Figure 21. Clinical Molecular Imaging System Report Years Considered
 Figure 22. Global Clinical Molecular Imaging System Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 23. Global Clinical Molecular Imaging System Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 24. Global Clinical Molecular Imaging System Market Share by Region: 2025 vs 2032
 Figure 25. Global Clinical Molecular Imaging System Market Share by Players in 2025
 Figure 26. Global Clinical Molecular Imaging System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 27. The Top 10 and 5 Players Market Share by Clinical Molecular Imaging System Revenue in 2025
 Figure 28. North America Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. North America Clinical Molecular Imaging System Market Share by Country (2021–2032)
 Figure 30. United States Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Canada Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Europe Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Europe Clinical Molecular Imaging System Market Share by Country (2021–2032)
 Figure 34. Germany Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. France Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. U.K. Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Italy Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Russia Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Ireland Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Asia-Pacific Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Asia-Pacific Clinical Molecular Imaging System Market Share by Region (2021–2032)
 Figure 42. China Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Japan Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. South Korea Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Southeast Asia Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. India Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Australia & New Zealand Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Latin America Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Latin America Clinical Molecular Imaging System Market Share by Country (2021–2032)
 Figure 50. Mexico Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Brazil Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 52. Middle East & Africa Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 53. Middle East & Africa Clinical Molecular Imaging System Market Share by Country (2021–2032)
 Figure 54. Israel Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 56. UAE Clinical Molecular Imaging System Market Size YoY Growth (US$ Million), 2021–2032
 Figure 57. Philips Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 58. GE Healthcare Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 59. Siemens Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 60. GMM Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 61. Hitachi Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 62. United-imaging Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 63. Shinva Medical Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 64. Kangda Medical Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 65. Wandong Medical Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 66. Canon Medical Revenue Growth Rate in Clinical Molecular Imaging System Business (2021–2026)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc